Thrombosis Research
Volume 121, Issue 3 , Pages 301-307 , 2007

Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis

  • Eduard J. Libourel

      Affiliations

    • Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • ,
  • Min Ki ten Kate

      Affiliations

    • Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • ,
  • Jan-Leendert P. Brouwer

      Affiliations

    • Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • ,
  • Nic J.G.M. Veeger

      Affiliations

    • Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • Research Coordination Center, Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands
    • ,
  • Jan van der Meer

      Affiliations

    • Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 50 3612791; fax: +31 50 3611790.

Received 10 January 2007 ,Revised 3 March 2007 ,Accepted 26 March 2007.

References 

  1. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87–111
  2. Daif A, Awada A, al-Rajeh S, Abduljabbar M, al Tahan AR, Obeid T, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193–1195
  3. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke. 1993;24:1880–1884
  4. Ferro JM, Canhào P, Stam J, Bousser MG, Barinagarrementeria F ISCVT investigators. Prognosis of cerebral vein and dural sinus thrombosis. Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664–670
  5. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis-a review of 38 cases. Stroke. 1985;16:199–213
  6. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke. 1996;27:243–246
  7. De Bruijn SFTM, Budde M, Teunisse S, Haan RJ, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology. 2000;54:1687–1689
  8. Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74:459–461
  9. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791–1798
  10. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107:2766–2773
  11. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155–160
  12. Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol. 1996;143:1257–1265
  13. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986;68:881–885
  14. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67
  15. Danneberg J, Abbes AP, Bruggeman BJ, Engel H, Gerrits J, Martens A. Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin). Clin Chem. 1998;44:349–351
  16. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost. 1991;65:320–322
  17. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43–52
  18. Den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759–762
  19. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood. 2003;102:1363–1366
  20. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765–1769
  21. De Bruijn SFTM, Stam J, Koopman MM, Vandenbroucke JP. Case–control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998;316:589–592
  22. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793–1797

PII: S0049-3848(07)00197-1

doi: 10.1016/j.thromres.2007.03.029

Thrombosis Research
Volume 121, Issue 3 , Pages 301-307 , 2007

Article Tools

* Image Usage & Resolution